Univ.-Prof. Dr. med.
Karl-Ludwig Laugwitz
Direktor

Selective Pressure-Regulated Retroinfusion for Gene Therapy Application in Ischemic Heart Disease.

Schlagzeile: 
Selective Pressure-Regulated Retroinfusion